Skip to content

Low Dose One-Day Tc99m Protocol With a High-Efficiency Cardiac Dedicated Gamma Camera For Detection of Coronary Disease

Validation of a Low-Dose One-Day TC99m Protocol With a High-Efficiency Cardiac Dedicated Gamma Camera for Detection of Coronary Artery Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01135095
Enrollment
101
Registered
2010-06-02
Start date
2010-06-30
Completion date
2013-04-30
Last updated
2021-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chest Pain

Keywords

Myocardial perfusion, Low radiation dose, Single photon emission computed tomography

Brief summary

A prospective single clinical trial to validate the use of a low-dose (\ 5mSv) Tc-99m protocol with a high-efficiency cardiac dedicated camera (Dynamic Single Photon Emission Computed Tomography; D-SPECT) to detect myocardial perfusion abnormalities during myocardial perfusion imaging.

Detailed description

as above

Interventions

The study is designed to assess the validity of a low dose (\ 5mSv) Tc99m one day protocol using D-SPECT standard protocol as the comparators. D-SPECT cardiac scanner the D-SPECT system uses a solid-state detector, made of an alloy of Cadmium, Zinc, and Telluride, eliminating the need for thick crystals and large photomultiplier tubes. As a result, the system is significantly miniaturized, and ergonomically optimized to both user and patient

Sponsors

PeaceHealth Medical Group
CollaboratorOTHER
Brigham and Women's Hospital
CollaboratorOTHER
Cedars-Sinai Medical Center
CollaboratorOTHER
Spectrum Dynamics
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

1. Patient is referred to myocardial perfusion D-SPECT for clinical indications. 2. Written informed consent is obtained by a study investigator.

Exclusion criteria

1. Patient is diagnosed as having uncontrolled congestive cardiac failure or cardiogenic shock. 2. Patient is diagnosed as having uncontrolled hypertension with resting blood pressure \> 220 mm Hg systolic or 110 mm Hg diastolic. 3. Patient pregnancy (known or suspected). 4. Lack of written informed consent 5. Prisoner status 6. Minors under the age of 18 as coronary artery disease is generally an adult disease

Design outcomes

Primary

MeasureTime frameDescription
Summed Rest Score (SRS) Using American Heart Association 17 Segment Polar Map Model1 daySRS is used to quantify presence/severity of SPECT rest myocardial perfusion defects, as assessed by visual analysis using American Heart Association (AHA) 17 segment polar map model; each segment correlates to a myocardial location. Perfusion abnormalities can be determined in relation to myocardial segment/s affected by ischemia and the perfusion defect severity scored using 0 - 4 scale for each segment (0, normal uptake; 1, mildly reduced uptake; 2, moderately reduced uptake; 3, severely reduced uptake; and 4, no uptake). SRS is calculated by summing individual scores from each of 17 segments to give an overall score between 0 and 68; a score of 0 indicates normal outcome and scores \> 0 indicate increasingly worse outcomes as the score increases. For each patient, SRS will be compared between standard-low-dose (SLD) imaging from a conventional A-SPECT camera and ultra-low-dose (ULD) imaging from a high-efficiency D-SPECT camera, both acquired on the same day.

Countries

United States

Participant flow

Recruitment details

101 patients prospectively enrolled at 3 US hospital sites (Cedars-Sinai Medical Center, Oregon Heart and Vascular Institute, Brigham and Women's Hospital) between June 2010 and June 2012.

Pre-assignment details

No post-enrollment pre-assignment significant events occurred.

Participants by arm

ArmCount
Low-dose Imaging
Low-dose versus standard dose imaging Low-dose imaging: the study is designed to assess the validity of a low dose (\ 5mSv) Tc99m one day protocol using D-SPECT standard protocol as the comparators. D-SPECT cardiac scanner: the D-SPECT system uses a solid-state detector, made of an alloy of Cadmium, Zinc, and Telluride, eliminating the need for thick crystals and large photomultiplier tubes. As a result, the system is significantly miniaturized, and ergonomically optimized to both user and patient.
101
Total101

Baseline characteristics

CharacteristicLow-dose Imaging
Age, Continuous63.8 years
STANDARD_DEVIATION 11.3
BMI26.1 Kg/m^2
STANDARD_DEVIATION 2.8
Current smoker13 Participants
Diabetes Mellitus26 Participants
Family history of premature heart disease31 Participants
Hyperlipidemia77 Participants
Hypertension74 Participants
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
101 participants
Sex: Female, Male
Female
47 Participants
Sex: Female, Male
Male
54 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 101
serious
Total, serious adverse events
0 / 101

Outcome results

Primary

Summed Rest Score (SRS) Using American Heart Association 17 Segment Polar Map Model

SRS is used to quantify presence/severity of SPECT rest myocardial perfusion defects, as assessed by visual analysis using American Heart Association (AHA) 17 segment polar map model; each segment correlates to a myocardial location. Perfusion abnormalities can be determined in relation to myocardial segment/s affected by ischemia and the perfusion defect severity scored using 0 - 4 scale for each segment (0, normal uptake; 1, mildly reduced uptake; 2, moderately reduced uptake; 3, severely reduced uptake; and 4, no uptake). SRS is calculated by summing individual scores from each of 17 segments to give an overall score between 0 and 68; a score of 0 indicates normal outcome and scores \> 0 indicate increasingly worse outcomes as the score increases. For each patient, SRS will be compared between standard-low-dose (SLD) imaging from a conventional A-SPECT camera and ultra-low-dose (ULD) imaging from a high-efficiency D-SPECT camera, both acquired on the same day.

Time frame: 1 day

Population: Patients with suspected or known coronary artery disease scheduled to undergo rest-stress 1 day 99mTc-based SPECT myocardial perfusion imaging.

ArmMeasureGroupValue (MEAN)Dispersion
Low-dose ImagingSummed Rest Score (SRS) Using American Heart Association 17 Segment Polar Map ModelSummed Rest Score Ultra-Low-Dose High-Efficiency SPECT imaging: D-SPECT camera2.75 score on a scaleStandard Deviation 5.41
Low-dose ImagingSummed Rest Score (SRS) Using American Heart Association 17 Segment Polar Map ModelSummed Rest Score Standard-Low-Dose A-SPECT imaging: Siemens ECAM/Symbia T6 or Philips Forte camera2.95 score on a scaleStandard Deviation 5.4

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026